Summary of Conference Call Notes Industry and Company Involved - The report focuses on the investment strategies and performance of various sectors, particularly in the machinery, electronics, and renewable energy industries. - Key companies mentioned include 博盈特焊 (Boyi Welding), 天华新能 (Tianhua New Energy), 广联航空 (Guanglian Aviation), 京东方A (BOE Technology Group), 三峡旅游 (Three Gorges Tourism), 超捷股份 (Chaojie Co.), 福元医药 (Fuyuan Pharmaceutical), and 宁波银行 (Ningbo Bank) [1][1][1]. Core Insights and Arguments - The report highlights two main functions: timely understanding of industry trends and significant excess returns from researched stocks [1]. - Recent fund manager research trends indicate a focus on the following sectors and companies: - **Growth**: Machinery, Electronics, Renewable Energy; top companies include 博盈特焊, 天华新能, 广联航空 [1]. - **Balanced**: Machinery, Renewable Energy, Non-ferrous Metals; top companies include 天华新能, 博盈特焊, 三峡旅游 [1]. - **Value**: Machinery, Electronics, Military Industry; top companies include 京东方A, 博盈特焊, 广联航空 [1]. - **TMT (Technology, Media, Telecommunications)**: Machinery, Electronics, Renewable Energy; top companies include 博盈特焊, 天华新能, 广联航空 [1]. - **Manufacturing**: Machinery, Renewable Energy, Automotive; top companies include 天华新能, 广联航空, 超捷股份 [1]. - **Consumer**: Pharmaceuticals, Electronics, Food and Beverage; top companies include 三峡旅游, 福元医药, 奥浦迈 [1]. - **Cyclical**: Non-ferrous Metals, Chemicals, Renewable Energy; top companies include 盛达资源, 天华新能, 亚太科技 [1]. - **Financials and Real Estate**: Automotive, Banking; top companies include 超捷股份, 宁波银行, 光庭信息 [1]. Additional Important Insights - An equal-weight index constructed from the stocks researched over the past six months shows a cumulative increase of 21% in H2 2025, significantly outperforming the Shanghai Composite Index's 15% increase [1]. - All types of fund research stock indices exhibit excess returns, particularly in the balanced, value, consumer, and financial real estate sectors compared to their respective fund averages [1].

- The report constructs an equal-weighted index based on the stocks investigated by fund managers over the past six months, with the "Research Stock-All Sample Index" achieving a cumulative return of 21.0%, outperforming the Shanghai Composite Index's 15.2% during the same period[5][13][14] - The "Research Stock-Growth Index" achieved a cumulative return of 20.5% over the past six months, surpassing the Shanghai Composite Index's 15.2% during the same period. Additionally, the representative fund's equal-weighted net value growth rate reached 29.2%, outperforming both the Growth Index and the Shanghai Composite Index[25][26][27] - The "Research Stock-Balanced Index" recorded a cumulative return of 25.7% over the past six months, exceeding the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 19.8%, which is lower than the Balanced Index but higher than the Shanghai Composite Index[32][33][34] - The "Research Stock-Value Index" achieved a cumulative return of 18.3% over the past six months, outperforming the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 8.8%, which is lower than both the Value Index and the Shanghai Composite Index[39][40][42] - The "Research Stock-Large Cap Index" achieved a cumulative return of 23.8% over the past six months, surpassing the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate reached 28.4%, outperforming both the Large Cap Index and the Shanghai Composite Index[51][52][54] - The "Research Stock-Mid Cap Index" recorded a cumulative return of 23.9% over the past six months, exceeding the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 23.0%, which is close to the Mid Cap Index and higher than the Shanghai Composite Index[61][62][61] - The "Research Stock-Small Cap Index" achieved a cumulative return of 19.2% over the past six months, outperforming the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 17.5%, which is lower than the Small Cap Index but higher than the Shanghai Composite Index[68][69][71] - The "Research Stock-TMT Index" achieved a cumulative return of 23.9% over the past six months, surpassing the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate reached 38.8%, outperforming both the TMT Index and the Shanghai Composite Index[79][80][79] - The "Research Stock-Manufacturing Index" recorded a cumulative return of 23.4% over the past six months, exceeding the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 29.4%, outperforming both the Manufacturing Index and the Shanghai Composite Index[87][88][87] - The "Research Stock-Consumer Index" achieved a cumulative return of 7.5% over the past six months, slightly outperforming the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 1.9%, which is lower than both the Consumer Index and the Shanghai Composite Index[94][95][94] - The "Research Stock-Cycle Index" recorded a cumulative return of 21.3% over the past six months, exceeding the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 29.2%, outperforming both the Cycle Index and the Shanghai Composite Index[100][101][100] - The "Research Stock-Financial Real Estate Index" achieved a cumulative return of 33.2% over the past six months, significantly outperforming the Shanghai Composite Index's 15.2%. The representative fund's equal-weighted net value growth rate was 7.7%, which is lower than both the Financial Real Estate Index and the Shanghai Composite Index[107][108][107]